within Pharmacolibrary.Drugs.ATC.M;

model M02AA08
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 1.6666666666666667e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M02AA08</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Felbinac is a non-steroidal anti-inflammatory drug (NSAID) primarily used for topical treatment of musculoskeletal pain and inflammation, such as in osteoarthritis, tendonitis or sports injuries. It acts by inhibiting prostaglandin synthesis through cyclooxygenase (COX) inhibition. Felbinac has been withdrawn or is not marketed/approved in some regions, but is still available in certain countries for topical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after topical administration of 3% felbinac gel.</p><h4>References</h4><ol><li><p>Bhardwaj, S, et al., &amp; Bhatia, S (2022). Potential Assessment of Topical Felbinac-Loaded Cubosomal Gel in Soft Tissue Injury in Albino Rats. <i>Assay and drug development technologies</i> 20(8) 367–376. DOI:<a href=\"https://doi.org/10.1089/adt.2022.063\">10.1089/adt.2022.063</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36534592/\">https://pubmed.ncbi.nlm.nih.gov/36534592</a></p></li><li><p>Shinkai, N, et al., &amp; Yamauchi, H (2008). Percutaneous penetration of felbinac after application of transdermal patches: relationship with pharmacological effects in rats. <i>The Journal of pharmacy and pharmacology</i> 60(1) 71–76. DOI:<a href=\"https://doi.org/10.1211/jpp.60.1.0009\">10.1211/jpp.60.1.0009</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18088507/\">https://pubmed.ncbi.nlm.nih.gov/18088507</a></p></li><li><p>Barkin, RL (2015). Topical Nonsteroidal Anti-Inflammatory Drugs: The Importance of Drug, Delivery, and Therapeutic Outcome. <i>American journal of therapeutics</i> 22(5) 388–407. DOI:<a href=\"https://doi.org/10.1097/MJT.0b013e3182459abd\">10.1097/MJT.0b013e3182459abd</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22367354/\">https://pubmed.ncbi.nlm.nih.gov/22367354</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M02AA08;
